Therdpong Tempark
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Therdpong Tempark has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
Siriwan Wananukul
Division of Pediatric Dermatology, Department of Pediatrics, Faculty of Medicine Chulalongkorn University Bangkok Thailand
12 shared publicationsSusheera Chatproedprai
Department of Pediatrics, Division of Dermatology, Chulalongkorn University, Bangkok, Thailand
11 shared publications- Suparuj Lueangarun
Department of Aesthetic Medicine, College of Integrative Medicine Dhurakij Pundit University Bangkok Thailand
8 shared publications - Siriwan Wananukul
Department of Pediatrics, Chulalongkorn University, Bangkok, Thailand
6 shared publications - Susheera Chatproedprai
Department of Pediatrics, Faculty of Medicine, Center of Excellence in Clinical Virology, Chulalongkorn University, Bangkok, 10330 Thailand
5 shared publications - Byong Seung Cho
ExoCoBio Exosome Institute (EEI) ExoCoBio Inc. Seoul Republic of Korea
4 shared publications
Latest Publications
- Open Access
- 21 April 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (9) , 1734-1736
The long-term impact of childhood and adolescent atopic dermatitis on physical and psychosocial wellbeing: Scars of Life project
The long-term impact of childhood and adolescent atopic dermatitis was assessed in a large international cohort of adults with resolved disease. Earlier onset was linked to greater physical and psychosocial impairment in adulthood, highlighting the persistent burden and need for early supportive interventions.
- 21 April 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (9) , 1734-1736
Open AccessThe long-term impact of childhood and adolescent atopic dermatitis on physical and psychosocial wellbeing: Scars of Life project
The long-term impact of childhood and adolescent atopic dermatitis was assessed in a large international cohort of adults with resolved disease. Earlier onset was linked to greater physical and psychosocial impairment in adulthood, highlighting the persistent burden and need for early supportive interventions.
- Open Access
- 11 April 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 195 (2) , 332-335
More than a symptom: itch as an independent clinical contributor in atopic dermatitis: a global-scale study on 15 223 patients
This international study of 15 223 patients with atopic dermatitis across 27 countries reveals that severe pruritus significantly impairs quality of life, affecting daily activities, professional careers and social relationships. Using validated tools like the ABS-A, SoL and PUSH-D, it underscores pruritus as a key independent factor in disease burden, highlighting the urgent need for its systematic evaluation and targeted management in clinical practice.
- 11 April 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 195 (2) , 332-335
Open AccessMore than a symptom: itch as an independent clinical contributor in atopic dermatitis: a global-scale study on 15 223 patients
This international study of 15 223 patients with atopic dermatitis across 27 countries reveals that severe pruritus significantly impairs quality of life, affecting daily activities, professional careers and social relationships. Using validated tools like the ABS-A, SoL and PUSH-D, it underscores pruritus as a key independent factor in disease burden, highlighting the urgent need for its systematic evaluation and targeted management in clinical practice.
- Open Access
- 26 April 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Atopic dermatitis starting in childhood has a stronger impact on adults: results from the ‘Scars of Life’ international project in 27 countries
Childhood-onset atopic dermatitis (AD) has a profound and lasting psychosocial impact compared with adult-onset AD. This study highlights higher stigmatization scores and greater relational, social and professional challenges in individuals whose AD started in childhood and continued into adulthood, compared with those whose AD started in adulthood, underscoring the need for comprehensive care that addresses both dermatological and psychological aspects of the disease.
- 26 April 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Open AccessAtopic dermatitis starting in childhood has a stronger impact on adults: results from the ‘Scars of Life’ international project in 27 countries
Childhood-onset atopic dermatitis (AD) has a profound and lasting psychosocial impact compared with adult-onset AD. This study highlights higher stigmatization scores and greater relational, social and professional challenges in individuals whose AD started in childhood and continued into adulthood, compared with those whose AD started in adulthood, underscoring the need for comprehensive care that addresses both dermatological and psychological aspects of the disease.
- Open Access
- 15 March 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (3) , e70115
Achieving Sustained Hair Repigmentation in Poliosis Circumscripta: Retreatment Outcomes Using Exosomes and Fractional Picosecond Laser
- 15 March 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (3) , e70115
Open AccessAchieving Sustained Hair Repigmentation in Poliosis Circumscripta: Retreatment Outcomes Using Exosomes and Fractional Picosecond Laser
- 4 November 2024
- Published by Wiley in Pediatric Dermatology
- Vol. 42 (1) , 79-87
Efficacy of a Video Education Program Regarding Basic Skin Care in Pediatric Atopic Dermatitis: A Randomized Controlled Trial
Background: Basic skin care education holds the potential to improve clinical outcomes in pediatric atopic dermatitis (AD). However, evidence is lacking on the efficacy of video education for patient guardians in Thailand to reduce AD disease severity.Objectives: To compare the efficacy of a video education program for guardians of pediatric AD patients versus a control group by assessing the severity score of AD (SCORAD), transepidermal water loss (TEWL), and skin hydration (SH).Methods: A single‐blinded, randomized controlled trial was conducted at a tertiary hospital from June 2023 to February 2024, involving AD patients aged < 18 years and their guardians. Both groups received standard treatment, and the educational group received an additional video education program. SCORAD, TEWL, SH, pruritus, sleeplessness, and parental/guardian confidence and knowledge accuracy were assessed at enrollment and a 4‐week follow‐up.Results: Seventy patients (educational:control group, 34:36) with a median age of 3.1 years were enrolled. The groups exhibited no significant demographic or disease severity differences between them. At follow‐up, the educational group showed significant SCORAD improvement compared to the control group (mean difference −10.93 [95% CI −16.92–−4.95]; p < 0.001). SH (mean difference 3.82 [95% CI −2.7–10.33]; p = 0.25) and TEWL (mean difference −1.24 [95% CI −5.72–3.24]; p = 0.58) did not differ significantly.Conclusions: Video education demonstrated efficacy in significantly reducing SCORAD. While there were improvements in SH and TEWL in patients in the education group, these improvements were not statistically significant. Further investigation with a larger sample size is warranted.Trial Registration: Thai Clinical Trials Registry (TCTR): TCTR20230524001
- 4 November 2024
- Published by Wiley in Pediatric Dermatology
- Vol. 42 (1) , 79-87
Efficacy of a Video Education Program Regarding Basic Skin Care in Pediatric Atopic Dermatitis: A Randomized Controlled Trial
Background: Basic skin care education holds the potential to improve clinical outcomes in pediatric atopic dermatitis (AD). However, evidence is lacking on the efficacy of video education for patient guardians in Thailand to reduce AD disease severity.Objectives: To compare the efficacy of a video education program for guardians of pediatric AD patients versus a control group by assessing the severity score of AD (SCORAD), transepidermal water loss (TEWL), and skin hydration (SH).Methods: A single‐blinded, randomized controlled trial was conducted at a tertiary hospital from June 2023 to February 2024, involving AD patients aged < 18 years and their guardians. Both groups received standard treatment, and the educational group received an additional video education program. SCORAD, TEWL, SH, pruritus, sleeplessness, and parental/guardian confidence and knowledge accuracy were assessed at enrollment and a 4‐week follow‐up.Results: Seventy patients (educational:control group, 34:36) with a median age of 3.1 years were enrolled. The groups exhibited no significant demographic or disease severity differences between them. At follow‐up, the educational group showed significant SCORAD improvement compared to the control group (mean difference −10.93 [95% CI −16.92–−4.95]; p < 0.001). SH (mean difference 3.82 [95% CI −2.7–10.33]; p = 0.25) and TEWL (mean difference −1.24 [95% CI −5.72–3.24]; p = 0.58) did not differ significantly.Conclusions: Video education demonstrated efficacy in significantly reducing SCORAD. While there were improvements in SH and TEWL in patients in the education group, these improvements were not statistically significant. Further investigation with a larger sample size is warranted.Trial Registration: Thai Clinical Trials Registry (TCTR): TCTR20230524001
- Open Access
- 11 September 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (18) , 5368
Integrative Treatment Approaches with Mind–Body Therapies in the Management of Atopic Dermatitis
Atopic dermatitis (AD) is a chronic inflammatory skin disease with a complex pathophysiology characterized by intense pruritus, often associated with psychological stress and atopic and non-atopic comorbidities that significantly reduce quality of life. The psychological aspects of AD and the interaction between the mind and body via the skin–brain axis have led to an interest in mind–body therapies (MBT). The aim of this article is, therefore, to reinforce the importance of psychodermatological care in AD. We performed a focused literature review on holistic practices or integrative MBT in AD, including education, cognitive behavioral therapy, habit reversal, meditation, mindfulness, hypnotherapy, eye movement desensitization and reprocessing, biofeedback, progressive muscle relaxation, autonomous sensory meridian response, music therapy, massage, and touch therapy. A multidisciplinary holistic approach with MBT, in addition to conventional pharmacologic antipruritic therapies, to break the itch–scratch cycle may improve AD outcomes and psychological well-being. Although there is a paucity of rigorously designed trials, evidence shows the potential benefits of an integrative approach on pruritus, pain, psychological stress, anxiety, depressive symptoms, and sleep quality. Relaxation and various behavioral interventions, such as habit reversal therapy for replacing harmful scratching with massaging with emollient ‘plus’, may reduce the urge to scratch, while education may improve adherence to conventional therapies.
- 11 September 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (18) , 5368
Open AccessIntegrative Treatment Approaches with Mind–Body Therapies in the Management of Atopic Dermatitis
Atopic dermatitis (AD) is a chronic inflammatory skin disease with a complex pathophysiology characterized by intense pruritus, often associated with psychological stress and atopic and non-atopic comorbidities that significantly reduce quality of life. The psychological aspects of AD and the interaction between the mind and body via the skin–brain axis have led to an interest in mind–body therapies (MBT). The aim of this article is, therefore, to reinforce the importance of psychodermatological care in AD. We performed a focused literature review on holistic practices or integrative MBT in AD, including education, cognitive behavioral therapy, habit reversal, meditation, mindfulness, hypnotherapy, eye movement desensitization and reprocessing, biofeedback, progressive muscle relaxation, autonomous sensory meridian response, music therapy, massage, and touch therapy. A multidisciplinary holistic approach with MBT, in addition to conventional pharmacologic antipruritic therapies, to break the itch–scratch cycle may improve AD outcomes and psychological well-being. Although there is a paucity of rigorously designed trials, evidence shows the potential benefits of an integrative approach on pruritus, pain, psychological stress, anxiety, depressive symptoms, and sleep quality. Relaxation and various behavioral interventions, such as habit reversal therapy for replacing harmful scratching with massaging with emollient ‘plus’, may reduce the urge to scratch, while education may improve adherence to conventional therapies.
- 27 July 2024
- Published by Maad Rayan Publishing Company in Journal of lasers in medical sciences
- Vol. 15, e24
Efficacy of 532-nm Nd: YAG Fractional Picosecond Laser with 9 mm High Coverage Handpiece Micro Lens Array in the Treatment of Facial Partial Unilateral Lentiginosis: A Case Report
Introduction: Facial partial unilateral lentiginosis (PUL) is an infrequent skin pigmentation disorder characterized by multiple lentigines. Despite the availability of various treatment modalities, there is no standard treatment for PUL. This study reports a successful treatment of facial PUL in a female patient using a novel 532-nm Nd:YAG fractional picosecond laser (FPL). Case Report: The patient underwent four treatment sessions at four-week intervals. The treatments were administered using a 9 mm high coverage handpiece micro lens array (MLA), with a fluence of 0.2–0.4 J/cm², a frequency of 2 Hz for 2-3 passes, and approximately 10% overlap. The treatment was well-tolerated by the patient, with significant improvement in pigmentation and no significant side effects observed. The outcomes confirmed the efficacy of the 532-nm Nd:YAG FPL in treating facial PUL. Conclusion: The 532-nm Nd:YAG FPL appears to be an effective and well-tolerated treatment for facial PUL, offering significant improvement in pigmentation without notable side effects.
- 27 July 2024
- Published by Maad Rayan Publishing Company in Journal of lasers in medical sciences
- Vol. 15, e24
Efficacy of 532-nm Nd: YAG Fractional Picosecond Laser with 9 mm High Coverage Handpiece Micro Lens Array in the Treatment of Facial Partial Unilateral Lentiginosis: A Case Report
Introduction: Facial partial unilateral lentiginosis (PUL) is an infrequent skin pigmentation disorder characterized by multiple lentigines. Despite the availability of various treatment modalities, there is no standard treatment for PUL. This study reports a successful treatment of facial PUL in a female patient using a novel 532-nm Nd:YAG fractional picosecond laser (FPL). Case Report: The patient underwent four treatment sessions at four-week intervals. The treatments were administered using a 9 mm high coverage handpiece micro lens array (MLA), with a fluence of 0.2–0.4 J/cm², a frequency of 2 Hz for 2-3 passes, and approximately 10% overlap. The treatment was well-tolerated by the patient, with significant improvement in pigmentation and no significant side effects observed. The outcomes confirmed the efficacy of the 532-nm Nd:YAG FPL in treating facial PUL. Conclusion: The 532-nm Nd:YAG FPL appears to be an effective and well-tolerated treatment for facial PUL, offering significant improvement in pigmentation without notable side effects.
- Open Access
- 9 July 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (11) , 3791-3794
Rose stem cell‐derived exosomes for hair regeneration enhancement via noninvasive electroporation in androgenetic alopecia
- 9 July 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (11) , 3791-3794
Open AccessRose stem cell‐derived exosomes for hair regeneration enhancement via noninvasive electroporation in androgenetic alopecia
- Open Access
- 3 June 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (10) , 3128-3132
Topical moisturizer with rose stem cell‐derived exosomes (RSCEs) for recalcitrant seborrheic dermatitis: A case report with 6 months of follow‐up
Introduction: Seborrheic dermatitis (SD) poses significant treatment challenges due to its chronic nature and the side effects associated with long‐term use of conventional therapies like topical corticosteroids. In the search for alternative treatments, exosomes, particularly those derived from rose stem cells (RSCEs), offer a promising avenue due to their potential in managing chronic skin conditions.Objective: This case report examines the efficacy of a topical moisturizer containing RSCEs in treating a patient with refractory SD, aiming to provide an alternative treatment pathway.Materials and Methods: A 40‐year‐old male with a long‐standing history of SD, unresponsive to traditional treatments, underwent a novel treatment regimen. This regimen included an initial topical application of 2.5 mL of RSCEs followed by a maintenance phase involving the application of a RSCE‐containing moisturizer. Clinical outcomes were assessed through the Patient's Global Assessment (PGA) and Investigator's Global Assessment (IGA) scores, along with evaluations of scaling and erythema.Results: Remarkable clinical improvement was noted as early as 1‐day post‐treatment, with significant reductions in redness, scaling, and itching. The patient experienced sustained relief throughout the 6‐month follow‐up, with a recurrence in the sixth month that was less severe than previous flare‐ups. This demonstrated not only the efficacy of RSCEs in symptom management but also their potential in extending remission periods.Conclusion: The chronic management of SD can benefit from innovative treatments like the RSCE‐containing moisturizer, as shown in this case report. While the observed outcomes are promising, indicating substantial improvements in skin condition and symptom management, larger controlled studies are necessary to validate the therapeutic potential of exosome‐containing moisturizers fully. This case underscores the need for alternative therapies in SD treatment, highlighting the role of exosomes as a viable option.
- 3 June 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (10) , 3128-3132
Open AccessTopical moisturizer with rose stem cell‐derived exosomes (RSCEs) for recalcitrant seborrheic dermatitis: A case report with 6 months of follow‐up
Introduction: Seborrheic dermatitis (SD) poses significant treatment challenges due to its chronic nature and the side effects associated with long‐term use of conventional therapies like topical corticosteroids. In the search for alternative treatments, exosomes, particularly those derived from rose stem cells (RSCEs), offer a promising avenue due to their potential in managing chronic skin conditions.Objective: This case report examines the efficacy of a topical moisturizer containing RSCEs in treating a patient with refractory SD, aiming to provide an alternative treatment pathway.Materials and Methods: A 40‐year‐old male with a long‐standing history of SD, unresponsive to traditional treatments, underwent a novel treatment regimen. This regimen included an initial topical application of 2.5 mL of RSCEs followed by a maintenance phase involving the application of a RSCE‐containing moisturizer. Clinical outcomes were assessed through the Patient's Global Assessment (PGA) and Investigator's Global Assessment (IGA) scores, along with evaluations of scaling and erythema.Results: Remarkable clinical improvement was noted as early as 1‐day post‐treatment, with significant reductions in redness, scaling, and itching. The patient experienced sustained relief throughout the 6‐month follow‐up, with a recurrence in the sixth month that was less severe than previous flare‐ups. This demonstrated not only the efficacy of RSCEs in symptom management but also their potential in extending remission periods.Conclusion: The chronic management of SD can benefit from innovative treatments like the RSCE‐containing moisturizer, as shown in this case report. While the observed outcomes are promising, indicating substantial improvements in skin condition and symptom management, larger controlled studies are necessary to validate the therapeutic potential of exosome‐containing moisturizers fully. This case underscores the need for alternative therapies in SD treatment, highlighting the role of exosomes as a viable option.
- Open Access
- 28 February 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (6) , 2307-2311
Hair repigmentation of poliosis circumscripta in androgenetic alopecia patient treated with exosomes and fractional picosecond laser
- 28 February 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (6) , 2307-2311
Open AccessHair repigmentation of poliosis circumscripta in androgenetic alopecia patient treated with exosomes and fractional picosecond laser